A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...
Vous n'êtes pas connecté
A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to immunotherapy—using just a blood test. Researchers have identified specific proteins in the blood that are strongly linked to how patients react to treatment. These proteins include ARG1, NOS3, and CD28. Using this information, the scientists […] The post New blood test predicts treatment success in aggressive breast cancer appeared first on Knowridge Science Report.
A groundbreaking study has discovered a way to predict whether patients with triple-negative breast cancer (TNBC) will respond well to...
A new study has identified a set of plasma proteins that can predict whether patients with triple-negative breast cancer (TNBC) will respond to...
Study finds specific genes that help predict how melanoma patients will respond to immunotherapy, paving the way for more personalized cancer...
A new study may offer a breakthrough for patients with advanced melanoma who don’t respond to current immunotherapy treatments. The research,...
A new study has shown that radiation therapy can make certain lung cancers more responsive to immunotherapy, even if they usually don’t respond to...
Most current cancer tests work by detecting biomarkers—molecules in the body that indicate a disease is present. These biomarkers are often produced...
A new review reveals how lactate and its derivative lactylation process drive breast cancer progression, opening new therapeutic possibilities. The...
Sucralose, an artificial sweetener used in many diet sodas and sugar-free foods, is often chosen by people who want to cut calories or manage blood...
Pancreatic cancer is one of the most dangerous cancers. It’s often discovered too late, when it has already spread, making treatment very hard. But...
Pancreatic cancer is one of the most dangerous cancers. It’s often discovered too late, when it has already spread, making treatment very hard. But...